Tiebang Kang

31PUBLICATIONS
104CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCell and nuclear divisionEpigenetics (incl. genome methylation and epigenomics)Virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 16, 2026
Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

|May 05, 2026
ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2.

|Feb 19, 2026
Ubiquitination at pericentromeric regions: directing heterochromatin reassembly during cell division.

Zhenxuan Chen, Tiebang Kang, Liwen Zhou

|May 29, 2025
ASB7 is a negative regulator of H3K9me3 homeostasis.

Liwen Zhou, Zhenxuan Chen, Yezi Zou

|Apr 29, 2025
The assembly of RAB22A/TMEM33/RTN4 initiates a secretory ER-phagy pathway.

Xueping Zheng, Dongmei Fang, Hao Shan

|Apr 21, 2025
Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1.

Xiaobo He, Qiu-Xia Wang, Denghui Wei

Pageof 6

Frequent Collaborators

10 joint publications

Yuanzhong Wu

8 joint publications

Song Gao

7 joint publications

Li Zhong

4 joint publications

Ying Gao